Topotecan (Hycamtin) in the Therapy of Recurrent Ovarian Carcinoma

Publisher： Karger

E-ISSN： 2296-5262|21|4|2-5

ISSN： 2296-5270

Source： Oncology Research and Treatment, Vol.21, Iss.4, 1999-01, pp. : 2-5

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Topotecan (Hycamtin®) in the Therapy of Small-Cell Lung Cancer

By  

Oncology Research and Treatment, Vol. 21, Iss. 4, 1999-01 ,pp. : 13-17

Karger

Access to resources Recommend Favorite

Importance of Topotecan in the Therapy of Ovarian Carcinoma, Today and Tomorrow

By  

Oncology Research and Treatment, Vol. 21, Iss. 4, 1999-01 ,pp. : 6-9

Karger

Access to resources Recommend Favorite

Haematological Evaluation of Weekly Therapy with Topotecan for the Treatment of Recurrent Ovarian Cancer Resistant to Platinum-Based Therapy

By  

Oncology, Vol. 73, Iss. 3-4, 2008-04 ,pp. : 177-184

Karger

Access to resources Recommend Favorite

Hycamtin in the Therapy of Non-Small-Cell Lung Cancer

By  

Oncology Research and Treatment, Vol. 21, Iss. 4, 1999-01 ,pp. : 18-21

Karger

Access to resources Recommend Favorite

p53 Gene Status and Response to Topotecan-Containing Chemotherapy in Advanced Ovarian Carcinoma

By  

Oncology, Vol. 69, Iss. 2, 2005-09 ,pp. : 154-158

Karger

Access to resources Recommend Favorite